Drug recall · October 9, 2024
Atorvastatin Calcium Tablets recall
Why: Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured for: Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827, USA, Manufactured by: Umedica Laboratories Pvt Ltd., Vapi Gujarat 396195, India, NDC: 75834-257-01.
- Lots / codes
Lot #: U24T0408A, Exp: 03/31/2026
- Quantity
- 2328 bottles
- Company
- Nivagen Pharmaceuticals Inc, Sacramento, CA
- Distribution
- Nationwide within the U.S
- Initiated
- September 24, 2024 · Voluntary: Firm initiated
- Classified
- October 2, 2024
- Reported
- October 9, 2024
- Ended
- July 1, 2026
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atorvastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.